APOL1 localization in normal kidney and nondiabetic kidney disease - Wikidata - awgldk - TriplyDB

APOL1 localization in normal kidney and nondiabetic kidney disease

APOL1 localization in normal kidney and nondiabetic kidney disease

http://www.wikidata.org/entity/Q24631960

about

The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease Kidney disease: new technologies translate mechanisms to cure Hypertension and chronic kidney disease: controversies in pathogenesis and treatment Addressing the global burden of chronic kidney disease through clinical and translational research APOL1 and nephropathy progression in populations of African ancestry The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease Knockdown of ApoL1 in Zebrafish Larvae Affects the Glomerular Filtration Barrier and the Expression of Nephrin Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress Explaining the racial difference in AKI incidence APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.APOL1 risk variants, race, and progression of chronic kidney disease APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis.Defining nephrotic syndrome from an integrative genomics perspective.Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 CKD hotspots around the world: where, why and what the lessons are. A CKJ review series.African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era.Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN)Protein domains of APOL1 and its risk variants.Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort Understanding the mechanisms of proteinuria: therapeutic implications Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans Characterization of circulating APOL1 protein complexes in African Americans Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.

P2860

Q24594836-0D67FD44-7FBD-4EC8-8387-66CD4E858688 Q24599916-FAD91D15-2332-4F40-8A14-40BEB4294A38 Q26825227-EFAB9219-8136-4EA1-9CAC-3E0589E186E6 Q26851271-D6CA56DA-52AD-4834-A05C-39CE98C83FC7 Q27014158-79AE89F4-E848-453F-9DC1-7EEF778C1EC4 Q27022275-0D079154-81BA-4AC0-BE38-D14F95B6CFB3 Q27027828-9A5D9674-B10B-4394-B383-A87DF221F6BC Q27313326-4B891884-815D-4075-B44E-69C1E68B0824 Q27343034-15590560-8422-45E1-8D52-A3244BE2A9EC Q28546164-81148073-9023-456A-B86D-86B61D6D609B Q33974656-4CBC2830-A206-4E2B-A8F2-4762321AF74B Q34001289-9AF8F6E2-4C38-4AD6-842F-B7B497B4D67A Q34336370-DF47F684-9D6C-4FDA-9E0F-5D95D950CBD3 Q34383679-66987ACC-1E3C-45D0-8BA3-758881C2ADAB Q34540191-72A77844-F0C7-415A-82F2-29CB478EA1F7 Q34560989-2B539B18-A70B-4A8C-8B62-487C94C16A83 Q34674987-8B2DDFFF-AA75-404E-8A2D-B5731BDE4705 Q34797825-EE23F90E-FAF8-4CAC-9BA7-B909692C96B2 Q35027300-A636F30E-7FE8-4824-AC8D-3C6AA4FC63E2 Q35033687-D4A14AA4-0EC4-43AC-9320-55D94C759776 Q35310700-16176BC2-4566-4022-BF95-793291236C6D Q35567885-DFA2BBF9-2237-47E3-A0EC-CF78AEFFAC0A Q35576129-476DEDEC-F853-4F20-A9C0-837F95B50F29 Q35612283-9B5B4B71-64CB-403D-8A5B-FEA76D30C760 Q35674836-BEB3010E-F393-4BAA-81AF-35FDF9081B47 Q35701311-E47426C3-EFE8-4BAC-9CBC-0BDEB8C780E7 Q35875993-F59911B7-47C6-4F03-BD21-B56F8AFC705F Q35886308-8D6752AC-43D4-45E8-9049-5EB07B899432 Q35950501-B4326174-9526-4ABA-99D4-6F64685304EA Q35966975-D22DF133-C38E-4B69-B8BA-C6C2560A421F Q36100123-17841D3D-1366-4AAC-952D-D127650505F2 Q36124605-F37AE7CC-6D51-4B44-BEAD-F6F9313F28DB Q36191484-C1325116-129E-4143-8E1E-F0F3A4429EB6 Q36223249-BC957C6D-6A61-48EF-B23F-7B73949E78A4 Q36399241-69595F0C-22B5-40CA-80C0-F29FB9FC0C95 Q36543107-4EAE4642-3FF1-4097-BF0A-502FC2B84C95 Q36551655-64E1370A-4FBC-4BB4-BF98-0AB1204FF0F3 Q36624682-0EAC8521-10EF-42BF-9864-084B8AAAFF6E Q36624724-B14BF231-EB3B-43CA-8921-6716B2B1E741 Q36707848-0FD2C495-BEB1-4652-9EFE-2C6F25729BA5

P2860

APOL1 localization in normal kidney and nondiabetic kidney disease

http://www.wikidata.org/entity/Q24631960

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

APOL1 localization in normal kidney and nondiabetic kidney disease

@ast

APOL1 localization in normal kidney and nondiabetic kidney disease

@en

APOL1 localization in normal kidney and nondiabetic kidney disease

@nl

type

label

APOL1 localization in normal kidney and nondiabetic kidney disease

@ast

APOL1 localization in normal kidney and nondiabetic kidney disease

@en

APOL1 localization in normal kidney and nondiabetic kidney disease

@nl

prefLabel

APOL1 localization in normal kidney and nondiabetic kidney disease

@ast

APOL1 localization in normal kidney and nondiabetic kidney disease

@en

APOL1 localization in normal kidney and nondiabetic kidney disease

@nl

P1433

Q24631960-D60D6F8B-C3C0-488C-8207-11A1BFC81E95

P1476

Q24631960-6E4D1022-27E5-4D13-B0A4-6FBB9C41966A

P2093

Q24631960-2C85214E-FD0D-488C-8C50-5B9BA249D056

Q24631960-7BF48AD6-D15D-448C-BD1F-F523E2174237

Q24631960-8629FA6A-BBC5-42B0-B604-D82FF4752DC8

Q24631960-B0543CC5-D351-4981-BBD4-D6269684403D

Q24631960-B3E068FA-FD88-49B6-B598-82D731B127FC

Q24631960-E568B9DC-E269-4F83-901E-5CA708001489

P2860

Q24631960-008B8E45-FFB7-41B5-94D2-D16C3D04A3C7

Q24631960-05341460-35F2-44B7-A3D7-CED1A4B28C96

Q24631960-101B6741-87FD-4B6A-B7FB-74F1EDFA1DDF

Q24631960-174BA5B3-1942-4D92-AE88-65BBCFED3782

Q24631960-24112632-F104-4A7A-9262-F6F147BB831C

Q24631960-25FC90DA-1DA5-4330-BA09-733B3B656451

Q24631960-26DFD542-5618-4F4A-B704-CC84BCC5B28E

Q24631960-27703395-013A-4F0D-B993-3589B73A2EA5

Q24631960-2A84C2D7-741B-4E3F-83C8-65AF2509F5F1

Q24631960-344ADA7A-9FB3-4906-9357-A6AFDE373FAA

P304

Q24631960-0C6094E3-5957-4EEA-90AE-3D7F2705327D

P31

Q24631960-B0A98131-A3DC-46FA-80B7-78F5167032A1

P3181

Q24631960-06ECAC92-0F44-4743-A262-A75C3AA68177

P356

Q24631960-7D393BB4-AA3F-41F8-8C8C-110C601D9905

P407

Q24631960-C74DE43A-E07E-438B-AF48-287F44176499

P433

Q24631960-1C1AAB89-911B-42A4-9EF5-86F2D81904AC

P478

Q24631960-68C566A9-DF37-4248-9790-BE0CF64BFFB6

P577

Q24631960-B213DA04-E41E-4B6C-9753-1EE6ACFA5E3D

P698

Q24631960-6521D579-B912-4A2A-8020-947C23CAD245

P932

Q24631960-59A59059-646B-4FE0-B20D-E1F2CC28B69F

P3181

P356

P1433

Journal of the American Society of Nephrology

P1476

APOL1 localization in normal kidney and nondiabetic kidney disease

@en

P2093

John F O'Toole

http://www.w3.org/2001/XMLSchema#string

John R Sedor

http://www.w3.org/2001/XMLSchema#string

Leslie A Bruggeman

http://www.w3.org/2001/XMLSchema#string

Martha Konieczkowski

http://www.w3.org/2001/XMLSchema#string

Santhi Ganesan

http://www.w3.org/2001/XMLSchema#string

Sethu M Madhavan

http://www.w3.org/2001/XMLSchema#string

P2860

C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense

Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes

The human apolipoprotein L gene cluster: identification, classification, and sites of distribution

The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue

Apolipoprotein L-I is the trypanosome lytic factor of human serum

Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes

Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

A map of human genome variation from population-scale sequencing

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

P304

2119-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1903733

http://www.w3.org/2001/XMLSchema#string

P356

10.1681/ASN.2011010069

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21997392

http://www.w3.org/2001/XMLSchema#string

P932

3231786

http://www.w3.org/2001/XMLSchema#string